Fosun International’s iKang Healthcare Group, Inc. KANG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,625,806
| Closed | -$94.3M | – | 341 |
|
|
2018
Q4 | $94.3M | Hold |
4,625,806
| – | – | 5.63% | 4 |
|
|
2018
Q3 | $83.7M | Hold |
4,625,806
| – | – | 4.01% | 6 |
|
|
2018
Q2 | $94.6M | Hold |
4,625,806
| – | – | 4.83% | 5 |
|
|
2018
Q1 | $92.3M | Buy |
4,625,806
+15,372
| +0.3% | +$258K | 5.8% | 4 |
|
|
2017
Q4 | $72.8M | Buy |
4,610,434
+1,039,296
| +29% | +$15M | 6.39% | 3 |
|
|
2017
Q3 | $48.1M | Buy |
3,571,138
+1,023,199
| +40% | +$13.7M | 4.79% | 9 |
|
|
2017
Q2 | $31.3M | Hold |
2,547,939
| – | – | 3.86% | 9 |
|
|
2017
Q1 | $37.2M | Hold |
2,547,939
| – | – | 4.65% | 8 |
|
|
2016
Q4 | $44.2M | Hold |
2,547,939
| – | – | 5.91% | 7 |
|
|
2016
Q3 | $46.1M | Buy |
2,547,939
+123,967
| +5% | +$2.28M | 5.17% | 8 |
|
|
2016
Q2 | $44.5M | Buy |
2,423,972
+242,519
| +11% | +$4.88M | 4.3% | 10 |
|
|
2016
Q1 | $47.7M | Hold |
2,181,453
| – | – | 3.39% | 11 |
|
|
2015
Q4 | $44.6M | Sell |
2,181,453
-679,097
| -24% | -$11.7M | 3.61% | 10 |
|
|
2015
Q3 | $42.3M | Buy |
2,860,550
+1,155,723
| +68% | +$18.7M | 3.57% | 9 |
|
|
2015
Q2 | $33M | Buy |
+1,704,827
| New | +$31.3M | 2.33% | 12 |
|
Fosun International's KANG Position: Q1 2019 in Review
Fosun International sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 4,625,806 shares — an estimated $94.3M sold.
Fosun International first reported a position in KANG in Q2 2015 and held it in 15 quarters. The position peaked at $94.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.
- Fosun International reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
- Fosun International sold 4,625,806 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $94.3M.
- Fosun International first reported a position in iKang Healthcare Group, Inc. in Q2 2015 and held it in 15 quarters.
- Fosun International's iKang Healthcare Group, Inc. position peaked at $94.6M in Q2 2018.
- 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.
Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.